Literature DB >> 20545612

Inhibiting breast cancer progression by exploiting TGFbeta signaling.

Sarah E Baxley1, Rosa Serra.   

Abstract

Transforming Growth Factor beta (TGFbeta) signaling influences most aspects of cellular function in addition to playing a major role in organ development, remodeling, and repair. Given the wide range of effects induced by TGFbeta, it is not surprising that alterations in TGFbeta signaling have been implicated in development and progression of many different cancer types. Within the context of breast cancer itself, TGFbeta is known to have a dual nature, being both tumor-suppressive during early breast cancer development and tumor-promoting during breast cancer metastasis. Targets for breast cancer therapeutics are greatly needed to decrease morbidity and mortality from this devastating disease. Here, we summarize what is known about TGFbeta in breast cancer progression and discuss potential TGFbeta targets for breast cancer therapeutics.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20545612     DOI: 10.2174/138945010792006771

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  3 in total

Review 1.  Wnt5a as an effector of TGFβ in mammary development and cancer.

Authors:  Rosa Serra; Stephanie L Easter; Wen Jiang; Sarah E Baxley
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-03-18       Impact factor: 2.673

2.  Loss of N-Myc interactor promotes epithelial-mesenchymal transition by activation of TGF-β/SMAD signaling.

Authors:  D J Devine; J W Rostas; B J Metge; S Das; M S Mulekar; J A Tucker; W E Grizzle; D J Buchsbaum; L A Shevde; R S Samant
Journal:  Oncogene       Date:  2013-06-17       Impact factor: 9.867

3.  TGFβ isoforms and receptors mRNA expression in breast tumours: prognostic value and clinical implications.

Authors:  Chenfeng Chen; Kong-Nan Zhao; Paul P Masci; Sunil R Lakhani; Annika Antonsson; Peter T Simpson; Luis Vitetta
Journal:  BMC Cancer       Date:  2015-12-24       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.